January 4, 2018 / 11:20 AM / a year ago

Sanofi says will work with Manila in spite of Dengvaxia ban

FILE PHOTO: French multinational pharmaceutical company SANOFI logo seen at their headquaters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo

PARIS (Reuters) - France’s Sanofi (SASY.PA) said on Thursday it would continue to cooperate with the Philippines’ Food and Drug Administration after the country suspended clearance for its controversial dengue vaccine Dengvaxia.

The Philippines government also fined Sanofi a symbolic $2,000 (£1,476.30) Health Secretary Francisco Duque told Reuters.

“Sanofi Pasteur confirms that in accordance with international and local laws, regulations and company standards, post-approval commitments for Dengvaxia, as described in the pharmacovigilance plan submitted to the Philippines FDA and other national regulatory authorities, have been – and will continue to be – fulfilled,” a Sanofi spokesman said.

Reporting by Matthias Blamont; Editing by Geert De Clercq

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below